𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Diphenhydramine kinetics following intravenous, oral, and sublingual dimenhydrinate administration

✍ Scribed by Joseph M. Scavone; Becki G. Luna; Jerold S. Harmatz; Lisa von Moltke; David J. Greenblatt


Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
272 KB
Volume
11
Category
Article
ISSN
0142-2782

No coin nor oath required. For personal study only.

✦ Synopsis


Eight healthy volunteers received 50 mg of dimenhydrinate, a theoclate salt of diphenhydramine, orally, sublingually, and intravenously on three separate occasions in random sequence. Plasma diphenhydramine concentrations during 12 h after each dose were measured by gas-liquid chromatography with nitrogen-phosphorous detection. Mean peak plasma concentrations after sublingual administration were slightly lower than after oral dosage (38.3 vs 47.8 ng ml-I), and the time of peak concentration was similar (2.6 vs 2.3 h after dose). These differences did not reach statistical significance. The mean total area under the plasma concentration-time curve (AUC) for sublingual administration was slightly but not significantly smaller than after oral dosage (221 vs 270 h ng ml-' ). Systemic availability of diphenhydramine after sublingual dimenhydrinate, measured by the ratio of oral AUC to intravenous AUC, was slightly less than after oral dimenhydrinate (0.58 vs 0.69, NS), and both were significantly less than 1.0. Thus sublingual and oral administration of dimenhydrinate result in comparable, but incomplete, systemic availability of diphenhydramine.


πŸ“œ SIMILAR VOLUMES


Pharmacokinetics and pharmacodynamics of
✍ Jack A. Cook; Paula J. Burger; Barbara M. Michniewicz; Gerald D. Nordblom; Gary πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 163 KB

The purpose of this study was to characterize CI-992 pharmacokinetics and pharmacokinetics/pharmacodynamics (PK/PD) in sodium deplete monkeys. Panels of monkeys were administered CI-992 as a 1 h intravenous infusions (0.1 and 1 mg kg -1 ) or as single oral doses (0, 10, 50, and 100 mg kg -1 ). Mean

Blood disposition and urinary excretion
✍ David R. Taft; Sean Nordt; Ganesh R. Iyer; Michael H. Schwenk πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 180 KB

The pharmacokinetic disposition of methazolamide (MTZ) was studied in five healthy volunteers following administration of a single oral dose. Drug concentrations in blood, plasma, and urine were measured by HPLC. Over the range of plasma concentrations observed in vivo, MTZ free fraction (measured b